Natalizumab Intravenous and Pms-Sodium Polystyrene Sulfonate
Determining the interaction of Natalizumab Intravenous and Pms-Sodium Polystyrene Sulfonate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: natalizumab
Brand name: Tysabri
Synonyms: Natalizumab
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Natalizumab Intravenous-Pneumococcal 13-valent conjugate vaccine
- Natalizumab Intravenous-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Natalizumab Intravenous-Pneumococcal Conjugate Vaccine (13-Valent)
- Natalizumab Intravenous-Pneumococcal Conjugate Vaccine (7-Valent)
- Natalizumab Intravenous-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Natalizumab Intravenous-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Pms-Sodium Polystyrene Sulfonate-Natalvirt 90 DHA
- Pms-Sodium Polystyrene Sulfonate-Natalvirt CA
- Pms-Sodium Polystyrene Sulfonate-Natazia
- Pms-Sodium Polystyrene Sulfonate-Nateglinide
- Pms-Sodium Polystyrene Sulfonate-Natelle Complete
- Pms-Sodium Polystyrene Sulfonate-Natelle One